Parkinson’s disease develops when nerve cells in a specific part of the brain gradually die off, cutting the supply of a chemical messenger called dopamine that controls movement. About 85% of cases are sporadic, meaning they arise from a complex mix of genetic susceptibility, environmental exposures, and aging rather than a single identifiable cause. The remaining 15% or so run in families and involve inherited gene mutations.
What Happens Inside the Brain
Deep in the midbrain sits a small region called the substantia nigra, home to neurons that produce dopamine. These neurons are unusually vulnerable for several reasons. They have extraordinarily long, highly branched nerve fibers with a massive number of connection points, which demands enormous energy. To keep up, the cells rely on a feed-forward system driven by calcium that ramps up energy production in their mitochondria (the tiny power plants inside each cell). The problem is that running this system on high most of the time generates excess reactive oxygen species, essentially corrosive byproducts that damage the cell from within.
At the same time, a small protein called alpha-synuclein begins to misfold and clump together inside these neurons, forming dense deposits known as Lewy bodies. These clumps interfere with normal cell functions and eventually kill the neuron. Elevated calcium inside the cell makes the situation worse by directly promoting alpha-synuclein clumping, activating enzymes that accelerate aggregation, and impairing the cell’s ability to clear out misfolded proteins.
What makes this process especially concerning is that misfolded alpha-synuclein can spread from one neuron to the next in a prion-like fashion. A seed of abnormal protein released by one dying cell gets taken up by a neighboring cell, where it acts as a template, corrupting normal alpha-synuclein. Over years, this chain reaction spreads through connected brain regions.
The Gut-Brain Connection
One of the more striking discoveries in recent decades is that Parkinson’s may not always start in the brain. Lewy body deposits have been found in the nerve cells lining the digestive tract, sometimes years before motor symptoms appear. Colon biopsies from early-stage patients show alpha-synuclein accumulation in gut neurons before any detectable brain pathology.
A leading theory, known as Braak’s hypothesis, proposes that an environmental trigger, possibly a pathogen or microbial product, contacts alpha-synuclein in gut or nasal neurons and kicks off the misfolding process. The aggregated protein then travels up the vagus nerve, a long nerve highway connecting the gut to the brainstem, eventually reaching the substantia nigra. Supporting this idea, large cohort studies from northern Europe found that people who had their vagus nerve surgically severed (a procedure once used for ulcer treatment) had a lower risk of developing Parkinson’s compared to the general population.
Genes That Raise the Risk
Around 15% of people with Parkinson’s have a family history of the disease. Several specific gene mutations are established causes. The LRRK2 gene is the most common genetic contributor, particularly in certain ethnic populations. Mutations in the SNCA gene (which encodes alpha-synuclein itself) directly increase the protein’s tendency to misfold. Variants in the GBA gene, which normally helps cells break down waste products, impair the cellular cleanup machinery and allow toxic proteins to accumulate. Other genes linked to familial Parkinson’s include PINK1, PRKN, and PARK7, all of which play roles in mitochondrial health or protein disposal.
Even among the 85% of cases classified as sporadic, genetic variation still matters. Many people carry common gene variants that individually raise risk by a small amount but collectively, combined with environmental exposures, tip the balance toward disease.
Environmental Exposures
Pesticide exposure is one of the strongest confirmed environmental risk factors. People who have used the herbicide paraquat or the insecticide rotenone are 2.5 times more likely to develop Parkinson’s than those who haven’t. Each chemical attacks cells through a different mechanism: rotenone directly poisons the mitochondrial energy chain, while paraquat generates a flood of reactive oxygen species. Both pathways converge on the same vulnerable dopamine neurons already running close to their metabolic limits. Other pesticides classified as mitochondrial inhibitors, including permethrin, remain in common use.
Head injury is another documented trigger. Among adults 55 and older, a traumatic brain injury raises the risk of a Parkinson’s diagnosis by 44% over the next five to seven years compared to people who suffered trauma elsewhere on the body. The relationship follows a dose-response pattern: mild TBI increases risk by about 24%, moderate to severe TBI by 50%, and having more than one TBI raises risk by 87%. The mechanism likely involves triggering or accelerating the same neuroinflammatory and protein-misfolding processes that underlie the disease.
Age and Sex
Age is the single biggest risk factor. Parkinson’s is rare before 50, but prevalence climbs steeply with each decade. By ages 60 to 64, roughly 331 per 100,000 people are living with the disease. That figure nearly triples to about 971 per 100,000 by ages 70 to 74, and peaks around 2,225 per 100,000 in the 85 to 89 age range. Men are affected more often than women across all age groups, with male prevalence peaking about five years earlier than female prevalence.
Why aging matters so much ties back to the biology: mitochondria accumulate damage over a lifetime, cellular cleanup systems slow down, and the already-stressed dopamine neurons lose their ability to keep up with repair demands.
Factors That May Lower Risk
Coffee and tea consumption have been consistently, if imperfectly, linked to lower Parkinson’s risk. Caffeine appears to delay onset in a dose-dependent way, with animal models and human data pointing in the same direction. One study found that drinking more than three cups of tea per day was associated with an onset delay of nearly eight years, while the same level of coffee consumption delayed onset by close to five years. The protective effect may be stronger in men than women, though combined analyses of both sexes still reach statistical significance. Interestingly, regular cola consumption (more than two cups daily) has also shown a protective trend, likely due to its caffeine content.
Smoking, paradoxically, has also been repeatedly associated with reduced Parkinson’s risk. This does not make smoking a reasonable preventive strategy given its overwhelming harms, but the association has helped researchers understand the biology of nicotine’s effects on dopamine pathways. Physical activity is another area of active interest, with regular exercise linked to both reduced risk and slower symptom progression in people already diagnosed.
Why There’s No Single Cause
For most people, Parkinson’s results from a collision of factors: genetic variants that make dopamine neurons slightly more fragile, environmental hits that stress those neurons further, and the accumulated wear of aging. One person might carry a GBA variant and spend decades around agricultural chemicals. Another might have no obvious risk factors beyond age and bad cellular luck. The disease converges on the same endpoint, the death of dopamine-producing neurons, but arrives there through different combinations of genetic predisposition, toxic exposure, protein misfolding, mitochondrial failure, and possibly signals traveling up from the gut. This is why no single prevention strategy exists and why two people with the same diagnosis can have very different histories leading up to it.